K. A. Jellinger

79.2k citations
1.1k papers · 53.8k · 13 hit papers · h-index 117

Impact in

  • Neurology top 0.01%
    • Parkinson's Disease Mechanisms and Treatments
    • Neurological disorders and treatments
    • Neurological diseases and metabolism
    • Neuroinflammation and Neurodegeneration Mechanisms
    • Neuroscience and Neuropharmacology Research
    • Genetic Neurodegenerative Diseases

Papers in

    • Parkinson's Disease Mechanisms and Treatments 249
    • Neurological disorders and treatments 131
    • Neurological diseases and metabolism 109
    • Cerebrovascular and genetic disorders 42
    • Alzheimer's disease research and treatments 176

K. A. Jellinger

1.1k papers receiving 50.5k citations

K. A. Jellinger's Hit Papers

Are dementia with Lewy bodies and Parkinson’s disease dementia the same disease? 2018 · 274 citations
2740+17+35Years since publication50010001.5k2.0k

Peers

K. A. Jellinger
Comparison fields: 5 of 216
  • Neurology 22.0k
  • Neurology 9.5k
  • Cellular and Molecular Neuroscience 11.5k
  • Physiology 12.4k
  • Psychiatry and Mental health 6.8k
Replace Glenda M. Halliday with:
Glenda M. Halliday Australia
David J. Brooks United Kingdom
Heiko Braak Germany
Yves Agid France
Harry V. Vinters United States
Andrew J. Lees United Kingdom
Anthony E. Lang Canada
Guy M. McKhann United States
C. D. Marsden United Kingdom
Costantino Iadecola United States
K. A. Jellinger relative to Glenda M. Halliday Australia Glenda M. Halliday's profile →
Citations per field
00.5×1.5×
Glenda M. Halliday · 1×
Citations per year

Countries citing papers authored by K. A. Jellinger

Since Specialization
Citations

This map shows the geographic impact of K. A. Jellinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. A. Jellinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. A. Jellinger more than expected).

Fields of papers citing papers by K. A. Jellinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. A. Jellinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. A. Jellinger. The network helps show where K. A. Jellinger may publish in the future.

Co-authors

The 25 scholars most cited alongside K. A. Jellinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with K. A. Jellinger Line = papers co-authored together K. A. Jellinger links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 1.1k papers — load more, or switch the sort, to bring in the rest.

#Work
1
Brain dopamine and the syndromes of Parkinson and Huntington Clinical, morphological and neurochemical correlations
Hit paper breakdown →
19732325
2
Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian Brains
Hit paper breakdown →
19891248
3
Accumulation of abnormally phosphorylated τ precedes the formation of neurofibrillary tangles in Alzheimer's disease
Hit paper breakdown →
1989726
4
Preliminary NINDS neuropathologic criteria for Steele‐Richardson‐Olszewski syndrome (progressive supranuclear palsy)
Hit paper breakdown →
1994689
5
Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease
Hit paper breakdown →
1998650
6
Diagnostic Criteria for Vascular Cognitive Disorders
Hit paper breakdown →
2014584
7
Alzheimer disease and cerebrovascular pathology: an update
Hit paper breakdown →
2002578
8
Pathology of Parkinson’s disease
Hit paper breakdown →
1991576
9
The overlap between vascular disease and Alzheimer’s disease - lessons from pathology
Hit paper breakdown →
2014557
10
Office of Rare Diseases Neuropathologic Criteria for Corticobasal Degeneration
Hit paper breakdown →
2002554
11
Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease
Hit paper breakdown →
1992512
12
Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis
Hit paper breakdown →
2012504
13 1991467
14 2010465
15 1991464
16 2003407
17 1995405
18 1990400
19 1996398
20 1999391

About K. A. Jellinger

K. A. Jellinger is a scholar working on Neurology, Physiology, Neurology, Cellular and Molecular Neuroscience and Psychiatry and Mental health, having authored 1.1k papers that have together received 53.8k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (249 papers), Alzheimer's disease research and treatments (176 papers), Neurological disorders and treatments (131 papers), Neurological diseases and metabolism (109 papers), Dementia and Cognitive Impairment Research (87 papers), Genetic Neurodegenerative Diseases (62 papers), Neuroscience and Neuropharmacology Research (48 papers) and Cerebrovascular and genetic disorders (42 papers). The work is most often cited by research in Neurology (22.0k citations), Neurology (9.5k citations), Cellular and Molecular Neuroscience (11.5k citations), Physiology (12.4k citations) and Psychiatry and Mental health (6.8k citations). K. A. Jellinger has collaborated with scholars based in Austria, Germany and United States. Frequent co-authors include Johannes Attems, F Seitelberger, C. Bancher, Peter Riederer, Gregor K. Wenning, Werner Paulus, Hans Lassmann, W Birkmayer, H. Bernheimer and Oleh Hornykiewicz. Their work appears in journals such as European Journal of Neurology, Acta Neuropathologica, Journal of Neural Transmission, Journal of Neurology and Journal of the Neurological Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact